EP3009511

MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Application Number
EP16150428A
Filing Date
Jan 7, 2016
Status
Patent Maintained As Amended
Dec 25, 2020
Grant Date
Jan 27, 2021
External Links
Slate, Register

Biblio Summary

The patent EP3009511B2 was granted on Jan 27, 2021 by Massachusetts Institute Of Technology The patent is currently Patent Maintained As Amended.

The table below shows 3 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBFeb 28, 2018 N.A.
STRAWMAN LIMITEDFeb 27, 2018 N.A.
WACHTERSHAUSER & HARTZFeb 27, 2018 N.A.

The table below shows the patents of Massachusetts Institute Of Technology that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3294873Targeting Bcl11A Enhancer Functional Regions For Fetal Hemoglobin ReinductionSep 18, 20241
EP3604532Novel Crispr Enzymes And SystemsMay 1, 20241
EP3237615Crispr Having Or Associated With Destabilization DomainsJul 26, 20232